{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T04:33:23Z","timestamp":1783571603034,"version":"3.55.0"},"reference-count":25,"publisher":"Spandidos Publications","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Oncol Lett"],"DOI":"10.3892\/ol.2020.11629","type":"journal-article","created":{"date-parts":[[2020,5,14]],"date-time":"2020-05-14T20:26:17Z","timestamp":1589487977000},"page":"931-938","source":"Crossref","is-referenced-by-count":10,"title":["Comparison of Risk of Ovarian Malignancy Algorithm and cancer antigen 125 to discriminate between benign ovarian tumor and early\u2011stage ovarian cancer according to imaging tumor subtypes"],"prefix":"10.3892","volume":"20","author":[{"given":"Young\u2011Jae","family":"Lee","sequence":"first","affiliation":[{"name":"Department of Obstetrics and Gynecology, University of Ulsan College of Medicine, Asan Medical Center, Seoul 05505, Republic of Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong\u2011Man","family":"Kim","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, University of Ulsan College of Medicine, Asan Medical Center, Seoul 05505, Republic of Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ji\u2011Sik","family":"Kang","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, University of Ulsan College of Medicine, Asan Medical Center, Seoul 05505, Republic of Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"So\u2011Hyun","family":"Nam","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, University of Ulsan College of Medicine, Asan Medical Center, Seoul 05505, Republic of Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dae\u2011Yeon","family":"Kim","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, University of Ulsan College of Medicine, Asan Medical Center, Seoul 05505, Republic of Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Young\u2011Tak","family":"Kim","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, University of Ulsan College of Medicine, Asan Medical Center, Seoul 05505, Republic of Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2249","published-online":{"date-parts":[[2020,5,14]]},"reference":[{"key":"key20200714152036_b1-ol-0-0-11629","doi-asserted-by":"publisher","first-page":"7","DOI":"10.3322\/caac.21332","article-title":"Cancer statistics, 2016","volume":"66","author":"Siegel","year":"2016","journal-title":"CA Cancer J Clin"},{"key":"key20200714152036_b2-ol-0-0-11629","doi-asserted-by":"publisher","first-page":"1331","DOI":"10.1172\/JCI110380","article-title":"Reactivity of a monoclonal antibody with human ovarian carcinoma","volume":"68","author":"Bast","year":"1981","journal-title":"J Clin Invest"},{"key":"key20200714152036_b3-ol-0-0-11629","doi-asserted-by":"publisher","first-page":"1054","DOI":"10.1016\/S1470-2045(07)70357-1","article-title":"Benign causes of increased serum CA-125 concentration","volume":"8","author":"Sevinc","year":"2019","journal-title":"Lancet Oncol"},{"key":"key20200714152036_b4-ol-0-0-11629","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/j.ejogrb.2008.08.011","article-title":"Accuracy of CA 125 in the diagnosis of ovarian tumors: A quantitative systematic review","volume":"142","author":"Medeiros","year":"2019","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"key20200714152036_b5-ol-0-0-11629","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1006\/gyno.2000.5811","article-title":"Serum CA 125, carcinoembryonic antigen, and CA 19-9 as tumor markers in borderline ovarian tumors","volume":"78","author":"Engelen","year":"2019","journal-title":"Gynecol Oncol"},{"key":"key20200714152036_b6-ol-0-0-11629","first-page":"548","article-title":"The emerging role of HE4 in the evaluation of epithelial ovarian and endometrial carcinomas","volume":"27","author":"Simmons","year":"2019","journal-title":"Oncology (Williston Park)"},{"key":"key20200714152036_b7-ol-0-0-11629","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1016\/j.bbrc.2012.02.008","article-title":"Human epididymis protein 4 (HE4) plays a key role in ovarian cancer cell adhesion and motility","volume":"419","author":"Lu","year":"2012","journal-title":"Biochem Biophys Res Commun"},{"key":"key20200714152036_b8-ol-0-0-11629","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1016\/S0378-1119(99)00342-X","article-title":"Comparative hybridization of an array of 21,500 ovarian cDNAs for the discovery of genes overexpressed in ovarian carcinomas","volume":"238","author":"Schummer","year":"1999","journal-title":"Gene"},{"key":"key20200714152036_b9-ol-0-0-11629","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1016\/j.cca.2015.03.047","article-title":"HE4 in the differential diagnosis of ovarian masses","volume":"446","author":"Granato","year":"2015","journal-title":"Clin Chim Acta"},{"key":"key20200714152036_b10-ol-0-0-11629","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1016\/j.ygyno.2012.03.011","article-title":"Serum HE4 concentration is not dependent on menstrual cycle or hormonal treatment among endometriosis patients and healthy premenopausal women","volume":"125","author":"Hallamaa","year":"2012","journal-title":"Gynecol Oncol"},{"key":"key20200714152036_b11-ol-0-0-11629","doi-asserted-by":"publisher","first-page":"349.e1","DOI":"10.1016\/j.ajog.2011.12.028","article-title":"Serum levels of the ovarian cancer biomarker HE4 are decreased in pregnancy and increase with age","volume":"206","author":"Moore","year":"2012","journal-title":"Am J Obstet Gynecol"},{"key":"key20200714152036_b12-ol-0-0-11629","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/j.ygyno.2008.08.031","article-title":"A novel multiple marker bioassay utilizing HE4 and CA125 for the prediction of ovarian cancer in patients with a pelvic mass","volume":"112","author":"Moore","year":"2009","journal-title":"Gynecol Oncol"},{"key":"key20200714152036_b13-ol-0-0-11629","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1097\/AOG.0b013e318224fce2","article-title":"Evaluation of the diagnostic accuracy of the risk of ovarian malignancy algorithm in women with a pelvic mass","volume":"118","author":"Moore","year":"2011","journal-title":"Obstet Gynecol"},{"key":"key20200714152036_b14-ol-0-0-11629","doi-asserted-by":"publisher","first-page":"2162","DOI":"10.1158\/0008-5472.CAN-04-3924","article-title":"Human epididymis protein 4 (HE4) is a secreted glycoprotein that is overexpressed by serous and endometrioid ovarian carcinomas","volume":"65","author":"Drapkin","year":"2005","journal-title":"Cancer Res"},{"key":"key20200714152036_b15-ol-0-0-11629","doi-asserted-by":"publisher","first-page":"e22624","DOI":"10.1002\/jcla.22624","article-title":"Diagnostic performance of CA 125, HE4, and risk of Ovarian Malignancy Algorithm for ovarian cancer","volume":"33","author":"Kim","year":"2019","journal-title":"J Clin Lab Anal"},{"key":"key20200714152036_b16-ol-0-0-11629","doi-asserted-by":"publisher","first-page":"1087","DOI":"10.1007\/s13277-011-0204-3","article-title":"HE4 a novel tumour marker for ovarian cancer: Comparison with CA 125 and ROMA algorithm in patients with gynaecological diseases","volume":"32","author":"Molina","year":"2011","journal-title":"Tumor Biol"},{"key":"key20200714152036_b17-ol-0-0-11629","first-page":"e162","article-title":"Is HE4 serum level a valid screening test in women candidates for kidney transplant? A case report and a review of literature","volume":"165","author":"Romeo","year":"2014","journal-title":"Clin Ter"},{"key":"key20200714152036_b18-ol-0-0-11629","doi-asserted-by":"publisher","first-page":"437","DOI":"10.6061\/clinics\/2012(05)06","article-title":"A comparison of CA125, HE4, risk ovarian malignancy algorithm (ROMA), and risk malignancy index (RMI) for the classification of ovarian masses","volume":"67","author":"Anton","year":"2012","journal-title":"Clinics (Sao Paulo)"},{"key":"key20200714152036_b19-ol-0-0-11629","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1016\/j.ygyno.2014.04.013","article-title":"2014 FIGO staging for ovarian, fallopian tube and peritoneal cancer","volume":"133","author":"Mutch","year":"2014","journal-title":"Gynecol Oncol"},{"key":"key20200714152036_b20-ol-0-0-11629","doi-asserted-by":"publisher","first-page":"1447","DOI":"10.1016\/j.cca.2011.04.028","article-title":"HE4 and epithelial ovarian cancer: Comparison and clinical evaluation of two immunoassays and a combination algorithm","volume":"412","author":"Ruggeri","year":"2011","journal-title":"Clin Chim Acta"},{"key":"key20200714152036_b21-ol-0-0-11629","doi-asserted-by":"publisher","first-page":"2081","DOI":"10.1515\/CCLM.2011.709","article-title":"The diagnostic accuracy of two human epididymis protein 4 (HE4) testing systems in combination with CA125 in the differential diagnosis of ovarian masses","volume":"49","author":"Lenhard","year":"2011","journal-title":"Clin Chem Lab Med"},{"key":"key20200714152036_b22-ol-0-0-11629","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1016\/j.ygyno.2012.09.034","article-title":"The use of HE4 in the prediction of ovarian cancer in Asian women with a pelvic mass","volume":"128","author":"Chan","year":"2019","journal-title":"Gynecol Oncol"},{"key":"key20200714152036_b23-ol-0-0-11629","doi-asserted-by":"publisher","first-page":"640","DOI":"10.1016\/j.ygyno.2015.06.021","article-title":"A novel diagnostic index combining HE4, CA125 and age may improve triage of women with suspected ovarian cancer-An international multicenter study in women with an ovarian mass","volume":"138","author":"Karlsen","year":"2015","journal-title":"Gynecol Oncol"},{"key":"key20200714152036_b24-ol-0-0-11629","doi-asserted-by":"publisher","first-page":"1586","DOI":"10.1097\/IGC.0000000000000804","article-title":"Diagnostic performance of risk of ovarian malignancy algorithm against CA125 and HE4 in connection with ovarian cancer: A Meta-analysis","volume":"26","author":"Dayyani","year":"2019","journal-title":"Int J Gynecol Cancer"},{"key":"key20200714152036_b25-ol-0-0-11629","article-title":"Berek and Novak's Gynecology 15th Edition","author":"Wolman","year":"2014","journal-title":"J Obstet Gynecol India"}],"container-title":["Oncology Letters"],"original-title":[],"deposited":{"date-parts":[[2020,8,12]],"date-time":"2020-08-12T19:37:26Z","timestamp":1597261046000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.spandidos-publications.com\/10.3892\/ol.2020.11629"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,5,14]]},"references-count":25,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2020,5,14]]}},"URL":"https:\/\/doi.org\/10.3892\/ol.2020.11629","relation":{},"ISSN":["1792-1074","1792-1082"],"issn-type":[{"value":"1792-1074","type":"print"},{"value":"1792-1082","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,5,14]]}}}